Test ID PGDBS Plasmalogens, Blood Spot
Additional Testing Requirements
If peroxisomal biogenesis disorders (Zellweger syndrome spectrum) are suspected, also order very long chain fatty acids (POX / Fatty Acid Profile, Peroxisomal [C22-C26], Serum; or POXP / Fatty Acid Profile, Peroxisomal [C22-C26], Plasma), bile acids (BAIPD / Bile Acids for Peroxisomal Disorders, Serum), and pipecolic acid (PIPU / Pipecolic Acid, Random, Urine).
If rhizomelic chondrodysplasia punctata (RCDP) is suspected, also order very long chain fatty acids (POX / Fatty Acid Profile, Peroxisomal [C22-C26], Serum), which includes phytanic and pristanic acid analysis.
Necessary Information
1. Reason for testing is required
2. Date of blood transfusion, if performed.
3. Biochemical Genetics Patient Information (T602) is recommended, but not required, to be filled out and sent with the specimen to aid in the interpretation of test results.
Specimen Required
Submit only 1 of the following specimens:
Preferred:
Patient Preparation: Specimen must be collected either prior to or 6 weeks after a blood transfusion.
Specimen Type: Blood spot
Supplies: Card-Blood Spot Collection (Filter Paper) (T493)
Container/Tube:
Preferred: Blood spot collection card
Acceptable: Local newborn screening card, PerkinElmer 226 filter paper, Munktell filter paper, Whatman Protein Saver 903 paper, or blood collected in tubes containing ACD, EDTA, or heparin spotted and dried on filter paper
Specimen Volume: 2 Blood spots
Collection Instructions:
1. An alternative blood collection option for a patient older than 1 year is a fingerstick. For detailed instructions, see How to Collect Dried Blood Spot Samples.
2. Let blood dry on the filter paper at ambient temperature in a horizontal position for a minimum of 3 hours.
3. Do not expose specimen to heat or direct sunlight.
4. Do not stack wet specimens.
5. Keep specimen dry.
Specimen Stability Information: Ambient (preferred) 90 days/Refrigerated 90days/Frozen 90 days
Additional Information:
1. For collection instructions, see Blood Spot Collection Instructions.
2. For collection instructions in Spanish, see Blood Spot Collection Card-Spanish Instructions (T777).
3. For collection instructions in Chinese, see Blood Spot Collection Card-Chinese Instructions (T800).
Acceptable
Specimen Type: Whole Blood
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Green top (sodium or lithium heparin), yellow top (ACD solution A or B)
Specimen Volume: 2 mL
Collection Instructions: Send whole blood specimen in original tube. Do not aliquot.
Specimen Stability Information: Refrigerate (preferred) 14 days/Ambient 11 days
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.
Useful For
Diagnosing patients with possible peroxisomal disorders, such as peroxisomal biogenesis disorders (Zellweger syndrome spectrum) and rhizomelic chondrodysplasia punctata (RCDP), including fatty acyl-CoA reductase 1 (FAR1) deficiency
Evaluating patients with abnormal newborn screen results for X-linked adrenoleukodystrophy who appear to have a different type of peroxisomal disorder, such as a Zellweger syndrome spectrum disorder
Aiding in the assessment of peroxisomal function
Genetics Test Information
This test measures plasmalogens and plasmalogen to fatty acid ratios for the purpose of diagnosis of peroxisomal biogenesis disorders (Zellweger syndrome spectrum) and rhizomelic chondrodysplasia punctata, including fatty acyl-CoA reductase 1 deficiency.
Highlights
This test analyzes plasmalogens and plasmalogen to fatty acid ratios. Reports include concentrations of C16:0, C18:0, and C18:1 plasmalogens and the ratio of the C16:0 and C18:0 plasmalogens to the respective fatty acid.
Special Instructions
Method Name
Gas Chromatography Mass Spectrometry (GC-MS)
Reporting Name
Plasmalogens, BSSpecimen Type
Whole bloodSpecimen Minimum Volume
Blood spot: 1
Whole blood: 0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole blood | Varies |
Reference Values
Hexadecanal-Dimethylacetal, C16:0 DMA
≥7.00 mcg/mL
Octadecanal-Dimethylacetal, C18:0 DMA
≥12.00 mcg/mL
9Z-Octadecenal-Dimethylacetal C18:1DMA
≥2.00 mcg/mL
C16:0 DMA/C16:0
≥0.012
C18:0 DMA/C18:0
≥0.050
Performing Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82542
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PGDBS | Plasmalogens, BS | 104687-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
609665 | Hexadecanal-Dimethylacetal, C16 DMA | 104682-0 |
609666 | Octadecanal-Dimethylacetal, C18 DMA | 104683-8 |
609667 | 9Z-Octadecenal-DiMe acetal C18:1DMA | 104684-6 |
609670 | C16 DMA/C16:0 | 104685-3 |
609671 | C18 DMA/C18:0 | 104686-1 |
BG724 | Reason for Referral | 42349-1 |
609673 | Reviewed By | 18771-6 |
609674 | Interpretation | 59462-2 |
NY State Approved
YesDay(s) Performed
Tuesday